Buprenorphine/naloxone 2/0.5mg Tablets 30ct Blister Card (Image 01)
Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 58118-1189
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 58118-1189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Buprenorphine-chem-structure.jpg (Image 02)
Bupr-naloxone-ifu-mouth-image (Image 03)
Naloxone-chem-structure.jpg (Image 04)
Buprenorphine/naloxone 8/2mg Tablets 30ct Blister Card (Image 05)
This is a list of clinical solutions including Buprenorphine/Naloxone 8/2mg with NDC 58118-1189-8 and quantity 30. It also mentions a product labeled as Mig. with NDC 00054-0189-13 and additional product details such as Lot #: SAMPLE123, Batch #: SAMPLE456, manufactured by Hikma Pharmaceuticals USA with an expiration date of 2027, located in Eatontown, NJ, USA. Additionally, there are some unclear characters at the end of the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
